fluorodeoxyglucose f18 has been researched along with Female Genital Neoplasms in 79 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 28 (35.44) | 29.6817 |
| 2010's | 40 (50.63) | 24.3611 |
| 2020's | 11 (13.92) | 2.80 |
| Authors | Studies |
|---|---|
| Fowler, KJ; Kusmirek, JE; McMillan, AB; Pirasteh, A; Sadowski, EA | 1 |
| Dong, A; Ji, X | 1 |
| Kiyono, Y; Makino, A; Mori, T; Okazawa, H; Tsujikawa, T; Tsuyoshi, H; Yoshida, Y | 1 |
| Larson, M; Lovrec, P; Pirasteh, A; Sadowski, EA | 1 |
| Dendl, K; Giesel, FL; Haberkorn, U; Koerber, SA; Watabe, T | 1 |
| Bhosale, PR; Derenoncourt, PR; Fraum, TJ; Ince, S; Itani, M; Konstantinoff, KS; Mhlanga, JC; Ponisio, MR; Sadowski, EA; Shetty, AS; Tarcha, Z; Zulfiqar, M | 1 |
| Bassett, R; Bhosale, P; Devine, C; Ganeshan, D; Kuchana, V; Virarkar, M | 1 |
| Bouchelouche, K; Donskov, F; Lindegaard, JC; Luong, TV; Mejlgaard, E | 1 |
| Hashimoto, K; Hatazawa, J; Kawano, M; Kimura, T; Kodama, M; Komura, N; Kozasa, K; Mabuchi, S; Matsumoto, Y; Sasano, T; Sawada, K; Shimura, K; Watabe, T; Yokoi, E | 1 |
| Benli, F; Güler, M; Ozmen, O; Tatci, E; Uslu Biner, I | 1 |
| Dehdashti, F; Friedman, SN; Itani, M | 1 |
| Arshad, M; Barwick, TD; Bharwani, N; Khan, SR; Stewart, V; Wallitt, K | 1 |
| Lin, M; Lin, P; Naik, N | 1 |
| Bhosale, PR; Devine, C; Faria, S; Javadi, S; Korivi, BR; Viswanathan, C | 1 |
| Grigsby, PW; Rao, YJ | 1 |
| Alpaugh, RK; Doss, M; Yu, JQ | 1 |
| Liu, Y | 1 |
| Graham, K; Harrand, R; Kerr, A; Reed, N; Sadozye, AH | 1 |
| Beriwal, S; Fulay, S; Kabolizadeh, P | 1 |
| Brunetti, J | 1 |
| Bhosale, PR; Shah, SN; Vikram, R; Viswanathan, C | 1 |
| Ebina, Y; Kitajima, K; Sugimura, K | 1 |
| Beiderwellen, K; Forsting, M; Gratz, M; Grueneisen, J; Heubner, M; Heusch, P; Kinner, S; Lauenstein, T; Ruhlmann, V; Schulze-Hagen, A; Umutlu, L | 1 |
| D'Hoore, A; Joniau, S; Kaur, M; Vergote, I | 1 |
| Balkay, L; Emri, M; Goda, K; Juhász, I; Krasznai, Z; Krasznai, ZT; Lajtos, I; Márián, T; Mikecz, P; Miklovicz, T; Németh, E; Szabó, G; Szalóki, G; Trencsényi, G | 1 |
| Grant, P; Jacene, HA; Sakellis, C | 1 |
| Hildebrandt, MG; Jensen, PT; Kodahl, AR; Mogensen, O; Teilmann-Jørgensen, D | 1 |
| Herrmann, K; Kohan, AA; Mihaloew, H; Paspulati, RM; Sherertz, T | 1 |
| Cho, YL; Chong, GO; Hong, DG; Lee, YH; Lee, YS | 1 |
| Kraeft, JJ; Lee, SI; Prabhakar, HB; Schorge, JO; Scott, JA | 1 |
| Aoki, D; Banno, K; Iida, M; Irie, H; Masugi, Y; Murakami, K; Nogami, Y | 1 |
| Freiwald-Chilla, B; Froehlich, JM; Hauser, N; Kubik-Huch, RA; Queiroz, MA; Veit-Haibach, P; von Schulthess, G | 1 |
| Agarwal, R; Babar, S; Blagden, S; Carme, S; Chen, M; Curry, E; Dina, R; El-Bahrawy, MA; Gabra, H; Gungor, H; Krachey, E; Madison, S; Morris, SR; Pickford, E; Rama, N; Saleem, A; Salinas, C; Santiago-Walker, A; Smith, DA; Stronach, EA | 1 |
| Egawa-Takata, T; Enomoto, T; Kimura, T; Kobayashi, E; Matsuzaki, S; Tanaka, Y; Tatsumi, M; Ueda, Y; Yoshino, K | 1 |
| Challapalli, A | 1 |
| Facchetti, L; Hernandez Pampaloni, M; Nardo, L | 1 |
| Chow, DZ; Goldberg-Stein, S; Kilcoyne, A; Lee, LK; Lee, SI | 1 |
| Brar, H; Han, K; Langer, D; MacCrostie, P; May, T; Metser, U; Tau, N | 1 |
| Lucignani, G | 1 |
| Bonomo, L; Calcagni, ML; De Gaetano, AM; Giordano, A; Gui, B; Rufini, V; Valentini, AL | 1 |
| Almusa, O; Daly, B; Shreve, P | 1 |
| Aschoff, P; Beckert, S; Brücher, BL; Glatzle, J; Hartmann, JT; Königsrainer, A; Königsrainer, I; Miller, S; Pfannenberg, C; Schroeder, TH; Zieker, D | 1 |
| Al-Nahhas, A; Ambrosini, V; Castellucci, P; Cracco, E; Fanti, S; Grassetto, G; Lopci, E; Maffione, AM; Marzola, MC; Massaro, A; Musto, A; Nanni, C; Piva, M; Rampin, L; Rubello, D; Tsamita, CS | 1 |
| Brooks, RA; Powell, MA | 1 |
| Enomoto, T; Hatazawa, J; Higuchi, I; Imaizumi, M; Inoue, A; Isohashi, K; Kato, H; Kimura, T; Nakajo, K; Shimosegawa, E; Tatsumi, M | 1 |
| Cho, A; Choi, YJ; Kim, CK; Lee, JD; Lee, JH; Yun, M | 1 |
| Lai, G; Rockall, AG | 1 |
| Avril, N; Gourtsoyianni, S; Reznek, R | 1 |
| Hickeson, M; Makis, W; Rakheja, R | 1 |
| Borgato, L; Cervino, AR; Dalla Palma, M; Evangelista, L; Fiduccia, P; Gregianin, M; Nicoletto, MO; Saladini, G; Zagonel, V | 1 |
| Gorospe, L; Jover-Díaz, R; Vicente-Bártulos, A | 1 |
| Avril, N; Cross, S; Flanagan, S; Moore, E; Rockall, AG | 1 |
| Brindle, JM; Debernardo, R; Kunos, C | 1 |
| Casanova, N; Imperiano, H; Miralbell, R; Popowski, Y; Ratib, O; Vees, H; Wang, H; Zaidi, H; Zilli, T | 1 |
| Kruse, V; Maes, A; Sathekge, M; Smeets, P; Van de Wiele, C | 1 |
| Amit, A; Keidar, Z; Person, O | 1 |
| Andikyan, V; Burger, IA; Chi, DS; Donati, OF; Goldman, DA; Gonen, M; Hricak, H; Sala, E; Schöder, H; Vargas, HA | 1 |
| Dehdashti, F; Siegel, BA | 1 |
| Siggelkow, W; Zimny, M | 1 |
| Futatsubashi, M; Kanno, T; Maeda, M; Nakamura, F; Okada, H; Ouchi, Y; Takekuma, M; Torizuka, T; Yoshikawa, E | 1 |
| Chang, TC; Hong, JH; Hsueh, S; Kao, PF; Lai, CH; Ng, KK; Tsai, CC; Tsai, CS; Yen, TC | 1 |
| Huglo, D; Vinatier, D | 1 |
| Almog, B; Even-Sapir, E; Fishman, A; Grisaru, D; Lerman, H; Lessing, JB; Levine, C; Metser, U | 1 |
| Conti, PS; Jadvar, H | 1 |
| Endo, K; Higuchi, T; Kanuma, T; Khan, N; Oriuchi, N; Yoshizaki, A | 1 |
| Barranger, E; Daraï, E; Grahek, D; Talbot, JN; Uzan, S | 1 |
| Lai, CH; Yen, TC | 1 |
| Even-Sapir, E; Lerman, H; Lievshitz, G; Metser, U; Safra, T; Zissin, R | 1 |
| Grahek, D; Talbot, JN | 1 |
| Ak, I; Ozalp, S; Stokkel, MP; Vardareli, E; Yalçin, OT; Zor, E | 1 |
| Akhurst, T; Alektiar, K; Barakat, RR; Chi, DS; Husain, A; Larson, S | 1 |
| Balachandran, A; Devine, CE; Iyer, RB | 1 |
| Haba, R; Hata, T; Kanenishi, K; Kushida, Y; Nishiyama, Y; Ohkawa, M; Ohno, M; Yamamoto, Y | 1 |
| Cousins, C; deSouza, NM; Dina, R; Fuchsel, F; McIndoe, GA; Mubashar, M; Peters, AM; Soutter, WP; Williams, AD | 1 |
| Adler, LP; Siegel, BA; Wahl, RL | 1 |
| Nabi, HA; Zubeldia, JM | 1 |
| Bosch, WR; Dempsey, JF; Grigsby, PW; Harms, WB; Laforest, R; Low, DA; Miller, TR; Mutic, S | 1 |
| Bellomi, M; Fazio, F; Landoni, C; Leo, F; Leon, ME; Pastorino, U; Pelosi, G; Picchio, M; Solli, PG; Sonzogni, A; Spaggiari, L; Veronesi, G | 1 |
41 review(s) available for fluorodeoxyglucose f18 and Female Genital Neoplasms
| Article | Year |
|---|---|
PET/MR imaging in gynecologic cancer: tips for differentiating normal gynecologic anatomy and benign pathology versus cancer.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Magnetic Resonance Imaging; Pelvis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2022 |
PET Imaging of Estrogen Receptors for Gynecological Tumors.
Topics: Breast Neoplasms; Endometrial Neoplasms; Estradiol; Estrogens; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Positron-Emission Tomography; Receptors, Estrogen | 2022 |
PET/MRI in Gynecologic Malignancy.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2023 |
Current Status of Fibroblast Activation Protein Imaging in Gynecologic Malignancy and Breast Cancer.
Topics: Breast Neoplasms; Female; Fibroblasts; Fluorodeoxyglucose F18; Gallium Radioisotopes; Genital Neoplasms, Female; Humans; Positron Emission Tomography Computed Tomography; Tomography, X-Ray Computed | 2023 |
Added Value of FDG PET/MRI in Gynecologic Oncology: A Pictorial Review.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals | 2023 |
Diagnostic value of PET/CT versus PET/MRI in gynecological malignancies of the pelvis: A meta-analysis.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Magnetic Resonance Imaging; Pelvis; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, X-Ray Computed | 2020 |
PET Imaging for Gynecologic Malignancies.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2021 |
What's New in Imaging for Gynecologic Cancer?
Topics: Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals | 2017 |
FDG-PET Assessment of Other Gynecologic Cancers.
Topics: Aged; Aged, 80 and over; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiographic Image Enhancement; Sensitivity and Specificity; Uterine Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms | 2018 |
The Role of PET Imaging in Gynecologic Radiation Oncology.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Ovarian Neoplasms; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiation Oncology; Radiographic Image Enhancement; Sensitivity and Specificity; Uterine Cervical Neoplasms; Uterine Neoplasms; Vulvar Neoplasms | 2018 |
Normal Variants and Pitfalls Encountered in PET Assessment of Gynecologic Malignancies.
Topics: Adult; Aged; Artifacts; False Positive Reactions; Female; Fluorodeoxyglucose F18; Genital Diseases, Female; Genital Neoplasms, Female; Humans; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiographic Image Enhancement; Risk Assessment; Sensitivity and Specificity | 2018 |
Evaluating the Use of 18F-FDG PET CT for External Beam Radiotherapy Planning in Gynaecological Malignancies.
Topics: Evaluation Studies as Topic; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted | 2018 |
PET/CT in gynecologic malignancies.
Topics: Contrast Media; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Radionuclide Imaging; Radiopharmaceuticals | 2013 |
Positron emission tomography-computed tomography imaging for malignancies in women.
Topics: Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2013 |
Present and future role of FDG-PET/CT imaging in the management of gynecologic malignancies.
Topics: Female; Fluorodeoxyglucose F18; Forecasting; Genital Neoplasms, Female; Genitalia, Female; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2014 |
Indications, techniques and outcomes for pelvic exenteration in gynecological malignancy.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Pelvic Exenteration; Positron-Emission Tomography; Tomography, X-Ray Computed; Treatment Outcome | 2014 |
Gynecologic oncologic imaging with PET/CT.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Positron-Emission Tomography; Tomography, X-Ray Computed | 2014 |
[¹⁸F]fluorodeoxyglucose PET/computed tomography in breast cancer and gynecologic cancers: a literature review.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
Positron emission tomography-magnetic resonance imaging in oncologic diseases of the male and female pelvis.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Genital Neoplasms, Male; Genitalia, Female; Genitalia, Male; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Pelvic Neoplasms; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals | 2014 |
FDG PET-CT of gynecologic cancers: pearls and pitfalls.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2015 |
New radiotracers in gynecological cancer: beyond ¹⁸F-FDG.
Topics: Animals; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Radioactive Tracers | 2016 |
Pitfalls in [¹⁸F]FDG PET imaging in gynecological malignancies.
Topics: Biological Transport; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Image Processing, Computer-Assisted; Positron-Emission Tomography | 2016 |
FDG PET-CT of Genitourinary and Gynecologic Tumors: Overcoming the Challenges of Evaluating the Abdomen and Pelvis.
Topics: Abdomen; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Male; Pelvis; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Urogenital Neoplasms | 2016 |
FDG-PET in gynaecological cancers: recent observations.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Ovarian Neoplasms; Positron-Emission Tomography; Radiography; Uterine Neoplasms | 2008 |
Imaging of gynecologic malignancies with FDG PET-CT: case examples, physiologic activity, and pitfalls.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Neoplasm Recurrence, Local; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Whole Body Imaging | 2009 |
[Selection criteria for peritonectomy with hyperthermic intraoperative chemotherapy (HIPEC) in peritoneal carcinomatosis].
Topics: Antineoplastic Agents; Carcinoma; Chemotherapy, Cancer, Regional Perfusion; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Gastrointestinal Neoplasms; Genital Neoplasms, Female; Humans; Hyperthermia, Induced; Laparoscopy; Patient Selection; Peritoneal Neoplasms; Peritoneum; Positron-Emission Tomography; Prognosis; Tomography, X-Ray Computed | 2008 |
Positron-emission tomography in gynaecologic malignancies.
Topics: Carcinoma; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Positron-Emission Tomography; Sarcoma; Sensitivity and Specificity | 2009 |
Novel imaging modalities in gynecologic cancer.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Magnetic Resonance Imaging; Neoplasm Recurrence, Local; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2009 |
Lymph node imaging in gynecologic malignancy.
Topics: Contrast Media; Dextrans; Diffusion Magnetic Resonance Imaging; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Image Enhancement; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Magnetite Nanoparticles; Nanoparticles; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radionuclide Imaging; Radiopharmaceuticals; Tomography, X-Ray Computed; Ultrasonography | 2010 |
PET/CT imaging in gynecologic malignancies: a critical overview of its clinical impact and our retrospective single center analysis.
Topics: Antineoplastic Agents; Biomarkers, Tumor; CA-125 Antigen; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lymph Nodes; Lymphatic Metastasis; Membrane Proteins; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Radiopharmaceuticals; Recurrence; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed; Tumor Burden | 2012 |
Spectrum of PET-CT pelvic pitfalls in patients with gynecologic malignancies.
Topics: Carcinoma, Squamous Cell; Clinical Protocols; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Multimodal Imaging; Patient Positioning; Positron-Emission Tomography; Pulmonary Embolism; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms | 2012 |
The role of FDG-PET/CT in gynaecological cancers.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
FDG PET/CT in monitoring response to treatment in gynecological malignancies.
Topics: Antineoplastic Agents; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Treatment Outcome | 2013 |
Evaluation of breast and gynecologic cancers by positron emission tomography.
Topics: Breast Neoplasms; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lymphatic Metastasis; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Positron emission tomography scanning in gynecologic and breast cancers.
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Predictive Value of Tests; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
[Utilization of PET scan in breast and gynaecologic cancers].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Ovarian Neoplasms; Tomography, Emission-Computed; Uterine Cervical Neoplasms | 2004 |
The reproductive tract.
Topics: Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Genital Neoplasms, Male; Humans; Male; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Prognosis; Radiopharmaceuticals; Treatment Outcome | 2004 |
[Role of [18F]-fluorodeoxyglucose positron emission tomography for the initial detection, staging, search for recurrences and restaging of gynaecological and breast cancers].
Topics: Adult; Breast Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Uterine Cervical Neoplasms; Uterine Neoplasms | 2005 |
Positron emission tomography in gynecologic cancer.
Topics: Clinical Trials as Topic; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Positron-Emission Tomography; Practice Guidelines as Topic; Practice Patterns, Physicians'; Radiopharmaceuticals | 2006 |
PET/CT and cross sectional imaging of gynecologic malignancy.
Topics: Contrast Media; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Magnetic Resonance Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Tomography, X-Ray Computed | 2007 |
Clinical applications of (18)F-FDG in oncology.
Topics: Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Head and Neck Neoplasms; Humans; Lung Neoplasms; Lymphoma; Melanoma; Radiopharmaceuticals; Skin Neoplasms; Tomography, Emission-Computed | 2002 |
5 trial(s) available for fluorodeoxyglucose f18 and Female Genital Neoplasms
| Article | Year |
|---|---|
Dose-Finding Quantitative 18F-FDG PET Imaging Study with the Oral Pan-AKT Inhibitor GSK2141795 in Patients with Gynecologic Malignancies.
Topics: Antineoplastic Agents; Biomarkers; Biopsy; Blood Glucose; Deoxyglucose; Diamines; Drug Interactions; Drug Resistance, Neoplasm; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Oncogene Protein v-akt; Positron-Emission Tomography; Pyrazoles; Radiopharmaceuticals; Treatment Outcome | 2015 |
Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET.
Topics: Adenocarcinoma; Adult; Aged; Carbon Radioisotopes; Carcinoma, Squamous Cell; Carcinosarcoma; Choline; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Ovarian Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sarcoma; Sarcoma, Clear Cell; Sensitivity and Specificity; Tomography, Emission-Computed; Uterine Neoplasms; Whole-Body Counting | 2003 |
The impact of image fusion in resolving discrepant findings between FDG-PET and MRI/CT in patients with gynaecological cancers.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2003 |
The diagnostic accuracy of 18F-fluorodeoxyglucose PET/CT in patients with gynecological malignancies.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Magnetic Resonance Imaging; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed; Ultrasonography | 2004 |
Diagnostic accuracy of FDG PET imaging for the detection of recurrent or metastatic gynecologic cancer.
Topics: Adult; Aged; Aged, 80 and over; Carcinoma; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2005 |
33 other study(ies) available for fluorodeoxyglucose f18 and Female Genital Neoplasms
| Article | Year |
|---|---|
FDG PET/CT in Prostate Metastasis From Gastric Cancer.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lymphatic Metastasis; Male; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Stomach Neoplasms | 2022 |
18F-FDG Uptake in a Mesonephric Carcinoma.
Topics: Adult; Biological Transport; Biopsy; Combined Modality Therapy; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Immunotherapy; Positron Emission Tomography Computed Tomography | 2020 |
Prognostic significance of bone marrow FDG uptake in patients with gynecological cancer.
Topics: Adult; Aged; Aged, 80 and over; Animals; Aorta; Bone Marrow; Cell Line, Tumor; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Granulocyte Colony-Stimulating Factor; Humans; Mice, Inbred C57BL; Middle Aged; Multivariate Analysis; Myeloid-Derived Suppressor Cells; Positron Emission Tomography Computed Tomography; Prognosis; Progression-Free Survival; Rats | 2021 |
Presentation of genital tuberculosis detected on FDG PET/CT scan resembling a primary gynecologic tumor and metastases.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Genitalia; Humans; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Stomach Neoplasms; Tuberculosis | 2021 |
Genitourinary involvement of lymphomas on FDG-PET.
Topics: Adrenal Gland Neoplasms; Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Genital Neoplasms, Male; Humans; Kidney Neoplasms; Lymphoma; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Ureteral Neoplasms; Urethral Neoplasms; Urinary Bladder Neoplasms; Urologic Neoplasms | 2018 |
Actinomycosis-induced adnexal and uterine masses mimicking malignancy on FDG PET/CT.
Topics: Actinomycosis; Adult; Diagnosis, Differential; Endometritis; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Salpingitis | 2019 |
Are Radiation Therapy Oncology Group Para-aortic Contouring Guidelines for Pancreatic Neoplasm applicable to other malignancies--assessment of nodal distribution in gynecological malignancies.
Topics: Adult; Aged; Aged, 80 and over; Anatomic Landmarks; Aorta; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Guideline Adherence; Humans; Lumbar Vertebrae; Lymph Nodes; Lymphatic Metastasis; Lymphography; Middle Aged; Multimodal Imaging; Pancreatic Neoplasms; Positron-Emission Tomography; Practice Guidelines as Topic; Psoas Muscles; Radiation Oncology; Radiopharmaceuticals; Radiotherapy, Intensity-Modulated; Renal Artery; Renal Veins; Retrospective Studies; Tomography, X-Ray Computed; Vena Cava, Inferior | 2013 |
Simultaneous positron emission tomography/magnetic resonance imaging for whole-body staging in patients with recurrent gynecological malignancies of the pelvis: a comparison to whole-body magnetic resonance imaging alone.
Topics: Adult; Aged; Cervix Uteri; Contrast Media; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Observer Variation; Ovarian Neoplasms; Ovary; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Uterine Cervical Neoplasms; Whole Body Imaging; Young Adult | 2014 |
18FDG, [18F]FLT, [18F]FAZA, and 11C-methionine are suitable tracers for the diagnosis and in vivo follow-up of the efficacy of chemotherapy by miniPET in both multidrug resistant and sensitive human gynecologic tumor xenografts.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Autoradiography; Carbon Radioisotopes; Cell Line, Tumor; Dideoxynucleosides; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Flow Cytometry; Fluorodeoxyglucose F18; Follow-Up Studies; Genital Neoplasms, Female; Humans; Methionine; Mice; Mice, SCID; Nitroimidazoles; Positron-Emission Tomography; Radiopharmaceuticals; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
Unabsorbed polylactide adhesion barrier mimicking recurrence of gynecologic malignant diseases with increased ¹⁸F-FDG uptake on PET/CT.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Neoplasm Recurrence, Local; Polyesters; Positron-Emission Tomography; Tomography, X-Ray Computed; Young Adult | 2015 |
Efficacy of 18-FDG PET-CT dual-phase scanning for detection of lymph node metastasis in gynecological cancer.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Tomography, X-Ray Computed | 2015 |
PET/MRI and PET/CT in advanced gynaecological tumours: initial experience and comparison.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neoplasm Metastasis; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Whole Body Imaging | 2015 |
Early metabolic change in (18)F-FDG-PET by measuring the single largest lesion predicts chemotherapeutic effects and patients' survival: PEACH study.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Platinum Compounds; Positron-Emission Tomography; Predictive Value of Tests; Statistics, Nonparametric; Survival Rate; Tomography, X-Ray Computed; Treatment Outcome | 2016 |
Detection of extra-regional tumour recurrence with
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies; Salvage Therapy; Sensitivity and Specificity | 2017 |
Protocol considerations for positron emission tomography-computed tomography of the abdomen and pelvis.
Topics: Abdominal Neoplasms; Colorectal Neoplasms; Contrast Media; Female; Fluorodeoxyglucose F18; Gastrointestinal Stromal Tumors; Genital Neoplasms, Female; Humans; Lymphoma; Lymphoproliferative Disorders; Pancreatic Neoplasms; Pelvic Neoplasms; Positron-Emission Tomography; Sarcoma; Stomach Neoplasms; Tomography, X-Ray Computed | 2008 |
Diagnostic performance of fluorodeoxyglucose positron emission tomography/magnetic resonance imaging fusion images of gynecological malignant tumors: comparison with positron emission tomography/computed tomography.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Hysterosalpingography; Image Enhancement; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Observer Variation; Ovarian Neoplasms; Ovary; Positron-Emission Tomography; Reproducibility of Results; Retrospective Studies; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Uterus | 2010 |
Physiologic 18F-FDG uptake in the fallopian tubes at mid cycle on PET/CT.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aging; Estrogens; Fallopian Tubes; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Image Interpretation, Computer-Assisted; Menstrual Cycle; Middle Aged; Ovariectomy; Pelvis; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed; Young Adult | 2010 |
Gynecological cancers.
Topics: Endometrial Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Neoplasm Staging; Ovarian Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Uterine Neoplasms | 2011 |
Extraovarian primary peritoneal carcinoma: staging with 18F-FDG PET/CT.
Topics: Aged; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Multimodal Imaging; Neoplasm Invasiveness; Neoplasm Staging; Peritoneal Neoplasms; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed | 2012 |
Stereotactic radiosurgery for gynecologic cancer.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Radiosurgery | 2012 |
Impact of 18F-FDG PET/CT on target volume delineation in recurrent or residual gynaecologic carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Genital Neoplasms, Female; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Neoplasm, Residual; Observer Variation; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Radiotherapy Planning, Computer-Assisted; Tomography, X-Ray Computed | 2012 |
Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours.
Topics: Carcinoma, Squamous Cell; Disease-Free Survival; Esophageal Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Glycolysis; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Medical Oncology; Neoplasm Staging; Neoplasms; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Treatment Outcome; Tumor Burden | 2013 |
The value of 18F-FDG PET/CT in recurrent gynecologic malignancies prior to pelvic exenteration.
Topics: Adult; Aged; Aged, 80 and over; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lymph Nodes; Lymphatic Metastasis; Middle Aged; Multimodal Imaging; Neoplasm Recurrence, Local; Pelvic Exenteration; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, X-Ray Computed | 2013 |
[2003 update of recommendations for clinical practice: standards, options and recommendations for the use of FDG-PET in the management of gynaecological and breast cancers].
Topics: Breast Neoplasms; Chemotherapy, Adjuvant; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Neoplasm Metastasis; Neoplasm, Residual; Ovarian Neoplasms; Tomography, Emission-Computed; Uterine Neoplasms; Vaginal Neoplasms | 2004 |
PET-CT findings in surgically transposed ovaries.
Topics: Adult; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Infertility, Female; Ovary; Positron-Emission Tomography; Radiopharmaceuticals; Radiotherapy; Tomography, X-Ray Computed | 2006 |
[Update of 'standards, options and recommendations' for FDG-PET in breast and gynaecological cancers].
Topics: Breast Neoplasms; Female; Fluorodeoxyglucose F18; France; Genital Neoplasms, Female; Humans; Neoplasm Metastasis; Ovarian Neoplasms; Practice Guidelines as Topic; Radiopharmaceuticals; Tomography, Emission-Computed; Uterine Neoplasms; Vaginal Neoplasms | 2006 |
F18-FDG coincidence-PET in patients with suspected gynecological malignancy.
Topics: Adenocarcinoma; Adnexal Diseases; Adult; Aged; Aged, 80 and over; False Negative Reactions; False Positive Reactions; Female; Fluorodeoxyglucose F18; Gamma Cameras; Genital Neoplasms, Female; Humans; Laparotomy; Leiomyoma; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed; Ultrasonography | 2006 |
A prospective study of the accuracy of 18Fluorodeoxyglucose positron emission tomography (18FDG PET) in identifying sites of metastasis prior to pelvic exenteration.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Magnetic Resonance Imaging; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Pelvic Exenteration; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Tomography, X-Ray Computed; Uterine Cervical Neoplasms; Vaginal Neoplasms; Vulvar Neoplasms | 2007 |
Monitoring the neoadjuvant therapy response in gynecological cancer patients using FDG PET.
Topics: Adult; Aged; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Middle Aged; Neoadjuvant Therapy; Outcome Assessment, Health Care; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies; Treatment Outcome | 2008 |
Detection of pelvic lymph node metastases in gynecologic malignancy: a comparison of CT, MR imaging, and positron emission tomography.
Topics: Adult; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lymph Node Excision; Lymphatic Metastasis; Magnetic Resonance Imaging; Pelvis; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2001 |
FDG positron emission tomography detection of pelvic nodal metastases in gynecologic cancer.
Topics: Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lymph Nodes; Lymphatic Metastasis; Magnetic Resonance Imaging; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2002 |
PET-guided three-dimensional treatment planning of intracavitary gynecologic implants.
Topics: Brachytherapy; Feasibility Studies; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Imaging, Three-Dimensional; Physical Phenomena; Physics; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Fluoro-deoxi-glucose uptake and angiogenesis are independent biological features in lung metastases.
Topics: Adult; Aged; Colorectal Neoplasms; Female; Fluorodeoxyglucose F18; Genital Neoplasms, Female; Humans; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Neovascularization, Pathologic; Prognosis; Radiopharmaceuticals; Retrospective Studies; Sarcoma; Tomography, Emission-Computed | 2002 |